Lung Cancer Detection Current Events | Lung Cancer Detection News | 6
|
| Page
6 of
140 |
2787 Results |
|
|
|
Sort By:
Page Views | Date |
Social class dictates cancer risk
Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy. view more (2008-09-26)
Defects in critical gene lead to accelerated lung tumor growth
Cancer causing mutations occur in our bodies every day - but luckily, we have specific genes that recognize these malignant events and keep cells from growing out of control. Only a few of these genes - called tumor suppressors - are currently known. view more (2007-08-06)
Profiling of cancer genes may lead to better and earlier detection
A research team at UT Southwestern Medical Center has for the first time identified several genes whose expression is lost in four of the most common solid human cancers - lung, breast, prostate and colon cancer. view more (2006-12-27)
Certain vitamin supplements may increase lung cancer risk, especially in smokers
Vitamin supplements do not protect against lung cancer, according to a study of more than 77,000 vitamin users. In fact, some supplements may even increase the risk of developing it. view more (2008-02-29)
PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting. view more (2009-11-09)
Researchers find potential celebrex target in lung cancer
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center. view more (2005-07-15)
Preventing lung scarring may extend lives of lung cancer patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life. view more (2007-10-30)
Anti-psychotic drugs could help fight cancer
The observation that people taking medication for schizophrenia have lower cancer rates than other people has prompted new research revealing that anti-psychotic drugs could help treat some major cancers. view more (2009-08-12)
Heavy smokers who cut their smoking in half may reduce their risk of lung cancer
Heavy smokers (more than 15 cigarettes per day) can reduce their risk of lung cancer if they decrease smoking by 50 percent, according to a study in the September 28 issue of JAMA. view more (2005-09-28)
Gene therapy may protect normal tissues during radiation retreatment for lung cancer
Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer. view more (2005-10-17)
Joining forces to improve lung cancer treatment
Prevention, personalized therapies and closer collaborations between surgeons, medical oncologists and radiation oncologists will result in better outcomes for lung cancer patients and those at risk, a leading European expert says. view more (2009-04-27)
Genetic parallels found between lung development and lung cancer
For over 100 years, biologists have speculated that cancer growth shares common features with embryonic development. view more (2006-07-05)
Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy
Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. view more (2009-08-03)
Lung cancer: Molecular scissors determine therapy effectiveness
In the past few years, a number of anti-cancer drugs have been developed which are directed selectively against specific key molecules of tumor cells. view more (2009-03-17)
Doctors commonly fail to detect lung cancer on chest x-ray films
Failure to detect lung cancer on chest x-rays is not uncommon, reveals research in Postgraduate Medical Journal. The ensuing delay in diagnosis and the start of treatment may contribute to some of the lowest survival rates in Europe for the disease, say the authors. view more (2002-03-04)
Researchers discover new way to predict survival in older women with lung cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a novel mechanism to predict survival in older women with early stage lung cancer. The finding may have significant implications for new treatment approaches. view more (2007-11-02)
Mutation database helps personalized treatment of lung cancer
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in... view more... (2008-04-25)
Novel EGFR antibody outperforms cetuximab in mouse model of lung cancer
Antibodies that selectively bind and destroy cancer cells represent some of the most promising cancer therapy approaches being developed today. Several of these antibodies have reached the market, including cetuximab (Erbitux®, ImClone Systems), which targets the epidermal growth factor receptor (EGFR) protein. view more (2007-01-29)
Cancer immunotherapy shows long-term promise in lung cancer
New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung... view more... (2008-04-25)
Preventative brain radiation for lung cancer patients: Benefits and risks
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain. view more (2009-11-03)
|
|
| Page
6 of
140 |
2787 Results |
|
|
|
Sort By:
Page Views | Date |
|
